Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (28)	2/4/1998 3:00:00 PM
From: squetch	Respond to of 4974

Rick, Checking in. I would find a discussion along these lines >>how does money flow in the sector, how is "private placement" leverage generated through innovative financing, and who wins and who loses<< very interesting. You are also one of the top 50 bookmarked people on SI. True. Regards, squetch

To: scaram(o)uche who wrote (28)	2/6/1998 5:32:00 PM
From: Biomaven	Respond to of 4974

Rick, Checking in. My email address is in my profile. (Caution: all these posts get archived by the search engines, and you may or may not want your email address available to the world at large). I'm an ex-high-tech-securities-attorney-type that now specializes in employee stock options. I'm also an avid amateur biotech investor (much more interesting <g>.) Speaking of private placements, did you see the large (>$150m) convertible preferred deal SEPR just announced? No announcement yet who bought it, but the substantial premium on the conversion price was interesting. The other "name" investor I've increasingly been coming across in biotech is Soros. He has an early stake in PCYC and last year took a late chunk of SEPR. Interesting thread! Peter

To: scaram(o)uche who wrote (28)	4/23/1998 1:49:00 AM
From: Rocketman	Read Replies (1) \| Respond to of 4974

Rick, You know me, I'm an amateur analyst and COO of the VDXXX Model Portfolio and Stock Swindlers & Manipulators Fund, currently under investigation by numerous fantasmical organizations and I am published extensively in the SI world. You can also find my Master's Thesis in through the University Microfilm Archive system, if the film hasn't degraded by now. The illustrious VDXXX CEO Vector1 suggested I check your thread and join you for brews, I like them dark and opaque, so none of those weenie lager bars please. I am a student, sporadic at times, of the history of biotech, having been a biotecher since the early 80's. Reading through your archive, I was amused to see your independent mention of INCY and Blech, and wanted to make the point that INCY was originally a Blech company, and that David B. put up the first mil that allowed the founders to buy the assets and technology of the liquidating Redwood City based R&D division of Invitron when it got liquidated. Randy Scott was the Director of R&D there, and Roy Whitfield was the CEO of Ideon which was an Invitron spinoff. They were going to be a drug company, but within about a year, in '92, when the drug company model went into death spiral due to a bad case of sepsis ie) Centocor, followed by Synergen (if I recall correctly, I tend to get some of the S companies confused), followed a bit later by XOMA. That year INCY adopted the drug discovery/genomics model, put the drugs in devo in the freezer and started sequencing like mad. The bioinformatics group at INCY, currently over 150 strong, started with one guy, Angelo Delegeane, using one MAC PLUS, that should be worth a grin. A great story on Blech was how he used to chew on his tie at meetings. He was fortunately never very involved in the operations at INCY and had dumped most of his shares before his brokerage fiasco....if the guy had only known what he held and hadn't screwed it up trying to be big Mr Brokerage scam artist he would have been sitting great now. Just worked the deal a bit too hard. Anyway, interesting thread so far and I've got another 100 posts or so to go. I'm pretty available for beers most nights except Tuesdays. Rocketman